Discover the top-performing biotech stocks in 2024! From oncology to psychedelics some companies showed remarkable results.

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Various PD-1 and PD-L1 checkpoint inhibitors have been approved by U.S. regulators including blockbuster drugs Keytruda, Imfinzi, and Opdivo to treat different types of cancer. But that hasn’t stopped ...

The month of December 2024 saw a variety of biotech deals take place to advance therapies across different stages in ...

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...